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Maternal adiposity in pregnancy and
offspring asthma in adulthood
To the Editor:
Adverse pre- and neonatal conditions, such as low birth weight and parental smoking, have, in recent years,
been found to increase the risk of developing asthma [1, 2]. The underlying mechanisms behind this appear
to include an altered epigenetic programming of the developing fetal airways and immune system [3, 4].
One of these prenatal risk factors is maternal adiposity. Obesity in pregnant women is increasing and it
has, in several cohort studies, been found to be associated with offspring asthma in childhood and in
adolescence [5, 6]. However, there are, to our knowledge, no previous studies focusing upon the
association between maternal body mass index (BMI) and offspring asthma in later life. The aetiologies of
asthma in adulthood differ from those of childhood asthma. Childhood asthma has a higher percentage of
the allergic phenotype, while late-onset asthma in adulthood is associated with a more rapid decline in
lung function [7, 8]. Therefore, the impact of maternal BMI on asthma might differ in paediatric and
adult cohorts. In this particular study, we examined the association between maternal adiposity and
offspring asthma in adulthood.
The study included 12027 subjects who were part of the Helsinki Birth Cohort Study (HBCS), a cohort of
13345 men and women born in Helsinki during 1934–1944. Information about the subjects and their
mothers was collected from hospital birth records, child welfare records and school health records. These
data include weight and length at birth, gestational age, maternal weight and height prior to delivery,
maternal age at birth, and parity. The subjects were divided into tertiles according to maternal BMI. The
mean maternal BMI was 23.4 kg·m−2 in the lowest tertile, 25.9 kg·m−2 in the middle group and
29.3 kg·m−2 in the highest tertile. Subjects’ occupations were acquired from Statistics Finland.
The prevalence of asthma was 7.1% for both sexes combined; 8.7% for women and 5.7% for men. The
occurrence of asthma was defined as receiving special reimbursement for asthma medication. The costs of
asthma medication are partly reimbursed by the state in Finland. In order to acquire special
reimbursement, certain criteria must be filled and in adults, the criteria require demonstration of reversible
airflow obstruction. The criteria for special reimbursement for asthma medication are further described in
detail by BARKER et al. [1].
We used Cox proportional hazard models as the primary analytical tool to examine the associations
between maternal adiposity and occurrence of asthma. The participants were followed up from the year
1964 to their death, migration, onset of asthma or December 31, 2011.
In the whole cohort, maternal BMI was significantly related to a higher occurrence of asthma. Compared
to those whose mothers were in the lowest BMI tertile, those whose mothers were in the highest tertile had
a higher hazard of asthma, the hazard ratio (HR) being 1.21 (95% CI 1.03–1.43). In the analysis for men
alone, the association was even stronger; HR was 1.44 (95% CI 1.12–1.86). Maternal BMI was not
associated with asthma among women. Additional adjustment for gestational age, parity, birth weight and
socioeconomic status in adulthood further strengthened the associations (figure 1). With both sexes
combined, the adjusted HR for asthma was 1.27 (95% CI 1.07–1.52) in the highest maternal BMI group
compared to the lowest group. For men, this HR was 1.54 (95% CI 1.18–2.02).
We also performed these analyses in a subsample (n=6874) with data on smoking history and adult BMI
available. There was no significant association between maternal BMI and offspring asthma before
adjustment for subjects’ own BMI or smoking status, although the trend was similar to the analyses
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performed with all subjects. Additionally, the results did not change when adding smoking status and
adult BMI as covariates.
With data from HBCS, we have examined the effect of maternal BMI in late pregnancy on the occurrence
of asthma in adult life in the offspring. While there are studies that have previously shown an association
between high maternal BMI and offspring asthma in childhood and adolescence, this is, to our knowledge,
the first study that demonstrated this association in late adult life particularly among men.
The mechanisms underlying the association between maternal BMI and offspring are likely to include
common genetic factors and environmental conditions as well as epigenetic remodelling during fetal
development. It is proposed that high maternal BMI during pregnancy causes an unfavourable hormonal
and metabolic environment for the fetus [9]. This in turn may result in epigenetic programming, which
adversely alters the development of the fetal immune system and results in a hyperresponsive airway
epithelium, a characteristic of asthma [10]. Further research is required to fully understand the pathways
by which maternal adiposity influences offspring asthma.
In this study, we found high maternal BMI to be associated with asthma in male, but not in female,
subjects. We are not able to draw any definite conclusions on why there is a sex difference. However, fetal
airway development differs in male and female fetuses, which hypothetically might expose the sexes
differently to adverse neonatal conditions [11]. Sex differences have also been described in several other
studies on neonatal conditions and later health outcome, supporting the theory that male and female
fetuses are targets for different epigenetic remodelling [12, 13].
The study has some limitations. As the medications for asthma and chronic obstructive lung disease partly
overlap, some of the subjects who received special reimbursement for asthma medication may in fact have
suffered from chronic obstructive lung disease instead of or in combination with asthma. This method
might also have excluded some mild cases of asthma, since the criteria for receiving the reimbursement
include using medication regularly. Maternal BMI was calculated by using maternal weight prior to
delivery and we were unable to distinguish between the impact of maternal pre-pregnancy weight and
maternal weight gain during pregnancy on offspring asthma. Nevertheless, high maternal BMI before
pregnancy and excessive gestational weight gain seem to have the same adverse effect on pregnancy and
neonatal outcomes [14]. Another challenge regarding maternal BMI is that the mothers in the cohort were
not as obese as pregnant women today.
The strengths of this study include a long follow-up period from birth until a mean age of 71 years, as well
as reliable information on maternal and neonatal characteristics from hospital birth records. We also
possessed information about the date of asthma diagnosis, which enabled us to perform the analyses with
Cox regression. Finally, the prevalence of asthma in the cohort was 7.1%, which corresponds well to the
general prevalence in the Finnish population [15].
In conclusion, this study suggests that maternal BMI in late pregnancy is associated with an increased
occurrence of asthma in male adult offspring after adjustment for year of birth, gestational age, parity,
birth weight and socioeconomic status in adulthood. The study gives us further insight into how pre- and
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FIGURE 1 Hazard ratios and 95% confidence intervals for special reimbursement for asthma medication
according to tertiles of maternal body mass index (BMI). Stratified for date of birth, and adjusted for sex when
both sexes are combined, and for gestational age, parity, birth weight and socioeconomic status in adulthood.
a) Men and women; b) men; c) women.
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neonatal conditions adversely affect the risk of asthma in later life. Further insight into the risk factors for
developing asthma might improve the possibilities for targeting primary prevention of the disease.
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